5 Results for "

CORL23

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CORL23" in MCE Product Catalog:

Cat. No.: HY-147193
CAS No.: 2567724-20-1
Purity:  98.70%
Target:  

NAMPT

Research Areas:  

Cancer

Nampt-IN-10 TFA (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 TFA shows cellular potency to A2780 and CORL23 cells lines with IC50s of 5 and 19 nM, respectively. Nampt-IN-10 TFA can be used as a novel non-antimitotic payload for ADCs .
loading...
    loading...
Cat. No.: HY-147193A
Target:  

NAMPT

Research Areas:  

Cancer

Nampt-IN-10 trihydrochloride (compound 4) is a Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-10 trihydrochloride shows cellular potency to A2780 and CORL23 cell lines with IC50 values of 5 and 19 nM, respectively. Nampt-IN-10 trihydrochloride can be used as a novel non-antimitotic payload for antibody-drug conjugate (ADC) .
loading...
    loading...
Cat. No.: HY-130606
CAS No.: 2380013-17-0
Purity:  98.02%
Target:  

NAMPT Cytochrome P450

Research Areas:  

Cancer

Nampt-IN-5 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. Nampt-IN-5 also inhibits CYP3A4 activity and has cellular IC50s of 0.7 nM and 3.9 nM against A2780 and COR-L23, respectively .
loading...
    loading...
Cat. No.: HY-P11356
CAS No.: 1932689-39-8
Target:  

Ras MHC

Research Areas:  

Cancer

KRAS G12V Peptide is a polypeptide and epitope derived from KRAS G12V. KRAS G12V Peptide forms a stable, high-affinity peptide-HLA class I complex, which is processed and presented by tumor cells and can be recognized by specific TCR. KRAS G12V Peptide is applicable to research related to metastatic lung cancer .
loading...
    loading...
Cat. No.: HY-P11356A
Target:  

Ras MHC

Research Areas:  

Cancer

KRAS G12V Peptide TFA is a polypeptide and epitope derived from KRAS G12V. KRAS G12V Peptide TFA forms a stable, high-affinity peptide-HLA class I complex, which is processed and presented by tumor cells and can be recognized by specific TCR. KRAS G12V Peptide TFA is applicable to research related to metastatic lung cancer .
loading...
    loading...